- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Net Cash Stocks With A Growth Track Record
U.S. Pharmaceuticals & Biotech Net Cash Stocks With A Growth Track Record
Results
2
0 new
These companies have grown profits at a double digit rate for 5 years or more. And they have net cash.
2 companies
Alkermes
Market Cap: US$4.8b
A biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally.
ALKS
US$28.98
7D
0.5%
1Y
2.8%
Niagen Bioscience
Market Cap: US$801.6m
Operates as a bioscience company engages in developing healthy aging products.
NAGE
US$10.04
7D
4.3%
1Y
187.7%